Vanguard Group Inc Moderna, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 41,708,705 shares of MRNA stock, worth $1.07 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
41,708,705
Previous 40,396,513 3.25%
Holding current value
$1.07 Billion
Previous $1.15 Billion 0.48%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$23.65 - $28.54 $31 Million - $37.4 Million
1,312,192 Added 3.25%
41,708,705 $1.15 Billion
Q1 2025

May 09, 2025
BUY
$28.35 - $47.53 $2.06 Million - $3.46 Million
72,763 Added 0.18%
40,396,513 $1.15 Billion
Q4 2024

Feb 11, 2025
BUY
$36.85 - $63.93 $3.59 Million - $6.24 Million
97,536 Added 0.24%
40,323,750 $1.68 Billion
Q3 2024

Nov 13, 2024
BUY
$63.64 - $125.14 $42.2 Million - $83 Million
663,418 Added 1.68%
40,226,214 $2.69 Billion
Q2 2024

Aug 13, 2024
BUY
$101.21 - $166.61 $53.2 Million - $87.6 Million
525,924 Added 1.35%
39,562,796 $4.7 Billion
Q1 2024

May 10, 2024
BUY
$85.37 - $115.44 $438 Million - $592 Million
5,129,800 Added 15.13%
39,036,872 $4.16 Billion
Q4 2023

Feb 14, 2024
BUY
$69.51 - $104.43 $434 Million - $653 Million
6,248,623 Added 22.59%
33,907,072 $3.37 Billion
Q3 2023

Nov 14, 2023
BUY
$96.41 - $126.61 $18.9 Million - $24.8 Million
196,012 Added 0.71%
27,658,449 $2.86 Billion
Q2 2023

Aug 14, 2023
SELL
$118.5 - $160.53 $7.62 Million - $10.3 Million
-64,312 Reduced 0.23%
27,462,437 $3.34 Billion
Q1 2023

Jul 14, 2023
BUY
$135.66 - $197.02 $63,624 - $92,402
469 Added 0.0%
27,526,749 $4.23 Billion
Q1 2023

May 15, 2023
BUY
$135.66 - $197.02 $33.1 Million - $48.1 Million
244,107 Added 0.89%
27,526,280 $4.23 Billion
Q4 2022

Feb 10, 2023
SELL
$118.38 - $210.04 $18.9 Million - $33.6 Million
-159,985 Reduced 0.58%
27,282,173 $4.9 Billion
Q3 2022

Nov 14, 2022
SELL
$118.07 - $194.18 $24.4 Million - $40.1 Million
-206,299 Reduced 0.75%
27,442,158 $3.25 Billion
Q2 2022

Aug 12, 2022
BUY
$117.13 - $176.59 $71.5 Million - $108 Million
610,265 Added 2.26%
27,648,457 $3.95 Billion
Q1 2022

May 13, 2022
SELL
$126.46 - $235.05 $49.1 Million - $91.3 Million
-388,378 Reduced 1.42%
27,038,192 $4.66 Billion
Q4 2021

Feb 14, 2022
BUY
$225.82 - $368.51 $55.4 Million - $90.3 Million
245,159 Added 0.9%
27,426,570 $6.97 Billion
Q3 2021

Nov 12, 2021
BUY
$221.9 - $484.47 $1.55 Billion - $3.38 Billion
6,986,507 Added 34.6%
27,181,411 $10.5 Billion
Q2 2021

Aug 13, 2021
BUY
$129.91 - $234.98 $2.62 Billion - $4.75 Billion
20,194,904 New
20,194,904 $4.75 Billion

Others Institutions Holding MRNA

# of Institutions
851
Shares Held
254M
Call Options Held
23.7M
Put Options Held
30.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email